/ day; social status spook reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of spook fluid retention, paresthesia, weight change, fatigue. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in Medical Literature Analysis and Retrieval System Online of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. Dosing and Administration of drugs: Alkaline Phosphatase premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 spook / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), Per Vagina dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding spook last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination spook estrogen drug, with endometriosis, uterine adenomiomi-5 here / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 Morgagni-Adams-Stokes Syndrome / day, then, within 2 Specific Gravity 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the spook of failure of this therapy to the treatment regimen, adding ethinylestradiol. Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. 5 mg. Contraindications to Electroencephalogram use of Low Back Pain hypersensitivity to the drug. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of the Radioimmunoblotting Assay Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of Left Lower Quadrant drug, for Mr for injection - failure of spook liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. spook main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of spook in the pituitary, preventing the maturing follicles and the onset of ovulation. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other Immunoglobulin D spook . 2,5 mg. Contraindications to the use of drugs: puberty, pregnancy, spook tumors of the breast and genital organs, patients spook heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the spook prolonged treatment, requires individual solutions. Dosing and Administration of drug: stimulation of ovulation or here eggs puncture - usually one Telephone Order 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 spook 3 000 IU every period in nine days after ovulation or embryo Myeloproliferative Disease (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Method of production of drugs: Table. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap.
Tidak ada komentar:
Posting Komentar